| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AI325008 ELISA Kit; BAD ELISA Kit; BAD_HUMAN ELISA Kit; BBC 2 ELISA Kit; BBC2 ELISA Kit; BBC6 ELISA Kit; Bcl 2 Antagonist of Cell Death ELISA Kit; Bcl 2 Binding Component 6 ELISA Kit; BCL X / BCL 2 Binding Protein ELISA Kit; BCL X Binding Protein ELISA Kit; Bcl XL/Bcl 2 Associated Death Promoter ELISA Kit; Bcl-2-binding component 6 ELISA Kit; Bcl-2-like protein 8 ELISA Kit; Bcl-XL/Bcl-2-associated death promoter ELISA Kit; Bcl2 antagonist of cell death ELISA Kit; BCL2 antagonist of cell death protein ELISA Kit; BCL2 associated agonist of cell death ELISA Kit; Bcl2 Associated Death Promoter ELISA Kit; BCL2 binding component 6 ELISA Kit; BCL2 binding protein ELISA Kit; Bcl2 Like 8 Protein ELISA Kit; Bcl2-L-8 ELISA Kit; BCL2L8 ELISA Kit; Proapoptotic BH3 Only Protein ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, cell culture supernates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
B-cell lymphoma-extra large (Bcl-xl)ELISA kit is a biological molecule commonly studied in cancer research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: Q07817
Biological context
Researchers often monitor B-cell lymphoma-extra large (Bcl-xl)ELISA kit in serum, plasma, and cell culture supernates to better understand themes such as tumor microenvironment biology, cell proliferation and apoptosis, and metastasis and invasion pathways. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in B-cell lymphoma-extra large (Bcl-xl)ELISA kit may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cell-cycle regulators, invasion/ECM markers, and immune-oncology mediators) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, B-cell lymphoma-extra large (Bcl-xl)ELISA kit may also appear under names such as AI325008 and BAD. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that B-cell lymphoma-extra large (Bcl-xl)ELISA kit participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
BCL-xL is correlated with disease severity in neonatal infants with early sepsis
W Wenshen,BMC pediatrics,2021
BCL-xL is Correlated With Disease Severity in Neonatal Infants With Sepsis
W Wu,Research Square,2021
Purification, extraction and analyses of fetal neurally-derived exosomes in maternal blood and neonatal neurally-derived exosomes from neonatal blood
Laura Goetzl, et al,/,2019